Sign in
  Edit search
Efficacy and safety results from the randomized controlled c…
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis %28CHAMPION%29.
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis %28CHAMPION%29.
Article, Chapter
Authors: J.H. Saurat
Publication: British Journal of Dermatology, Volume:158, Issue:3
Published: John Wiley and Sons, Ltd, 2008
ISSN: 0007-0963
  Full text availability for this item
View Full Text Source:British Journal of Dermatology,British Journal of Dermatology,Wiley Online Library: Complete Journals Opens in new Window
Journal:  British Journal of Dermatology Source:Wiley Online Library: Complete Journals Opens in new Window
Collection:  Wiley Online Library: Complete Journals Opens in new Window
Coverage:
  • 1892-02-01~2022-12-01; volume:4;issue:2~volume:187;issue:6
View Full Text Source:British Journal of Dermatology,British Journal of Dermatology,Wiley Online Library Database Model 2021 Opens in new Window
Journal:  British Journal of Dermatology Source:Wiley Online Library Database Model 2021 Opens in new Window
Collection:  Wiley Online Library Database Model 2021 Opens in new Window
Coverage:
  • 1997~present; volume:136~present;issue:1~present
Full Text Available
Journal:  British journal of dermatology : improving patient outcomes in skin disease worldwide / Source:Oxford University Press Journals (UKB 2021-2023) Opens in new Window
Collection:  Oxford University Press Journals (UKB 2021-2023)
Coverage:
  • 1996~present; volume:34~present;issue:1~present
Browse related articles
  Print copies at your library
Check availability in RUQuest
  Request a copy of this item
Cite this item